Selegiline (Eldepryl, Movergan, Zelepar), also known as deprenyl, is an antioxidant drug that blocks monoamine oxidase B (MAO-B), an enzyme that degrades dopamine. Until recently, selegiline was the drug most commonly used in early-onset disease and in combination with levodopa for maintenance. A major 2002 study reported, however, that although selegiline delays the need for L-dopa by a few months, it has no effect on long-term progression.
Rasagi...
Read more »...debated, but one thing's for sure: Sugar and lack of sleep depress the immune system, so... Read more »
Sleep studies... Read more »
BINGHAMTON, N.Y. (Ivanhoe Broadcast News) -- Five million people in the United States are living with Alzheimers, and though the vast majority of... Read summary »
(Ivanhoe Newswire) -- A nightcap while you're pregnant may disturb your child's sleep later on. A new study found alcohol consumption during... Read summary »
(Ivanhoe Newswire) -- Experts say about one-third of older adults experience dangerous falls each year -- and a new study says lack of sleep may be... Read summary »
(Ivanhoe Newswire) -- A new study adds to growing evidence that sleep is associated with weight. The research finds children and teens who sleep less... Read summary »
(Ivanhoe Newswire) -- A long, uninterrupted night's sleep is good medicine for Alzheimer's patients with obstructive sleep apnea (OSA). New research... Read summary »